TR201808196T4 - Mcm5 bağlayan monoklonal antikorlar. - Google Patents

Mcm5 bağlayan monoklonal antikorlar. Download PDF

Info

Publication number
TR201808196T4
TR201808196T4 TR2018/08196T TR201808196T TR201808196T4 TR 201808196 T4 TR201808196 T4 TR 201808196T4 TR 2018/08196 T TR2018/08196 T TR 2018/08196T TR 201808196 T TR201808196 T TR 201808196T TR 201808196 T4 TR201808196 T4 TR 201808196T4
Authority
TR
Turkey
Prior art keywords
antibody
sequence
mcm5
sek
light chain
Prior art date
Application number
TR2018/08196T
Other languages
English (en)
Turkish (tr)
Inventor
Alfred Laskey Ronald
Stoeber Kai
Original Assignee
Arquer Diagnostics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arquer Diagnostics Ltd filed Critical Arquer Diagnostics Ltd
Publication of TR201808196T4 publication Critical patent/TR201808196T4/tr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3069—Reproductive system, e.g. ovaria, uterus, testes, prostate
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against enzymes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57555—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the prostate
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57557—Immunoassay; Biospecific binding assay; Materials therefor for cancer of other specific parts of the body, e.g. brain
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5758—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites
    • G01N33/57595—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites involving intracellular compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4703—Regulators; Modulating activity
    • G01N2333/4706—Regulators; Modulating activity stimulating, promoting or activating activity

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Reproductive Health (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
TR2018/08196T 2015-06-08 2016-06-01 Mcm5 bağlayan monoklonal antikorlar. TR201808196T4 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1509907.0A GB201509907D0 (en) 2015-06-08 2015-06-08 Antibodies

Publications (1)

Publication Number Publication Date
TR201808196T4 true TR201808196T4 (tr) 2018-07-23

Family

ID=53785114

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2018/08196T TR201808196T4 (tr) 2015-06-08 2016-06-01 Mcm5 bağlayan monoklonal antikorlar.

Country Status (8)

Country Link
US (2) US20180186892A1 (https=)
EP (1) EP3221352B1 (https=)
JP (3) JP2018520127A (https=)
CN (1) CN107810200B (https=)
ES (1) ES2678049T3 (https=)
GB (1) GB201509907D0 (https=)
TR (1) TR201808196T4 (https=)
WO (1) WO2016198834A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201509907D0 (en) * 2015-06-08 2015-07-22 Urosens Ltd Antibodies
GB201820868D0 (en) * 2018-12-20 2019-02-06 Arquer Diagnostics Ltd Detection method
GB201820867D0 (en) * 2018-12-20 2019-02-06 Arquer Diagnostics Ltd Detection method
GB201912605D0 (en) * 2019-09-02 2019-10-16 Arquer Diagnostics Ltd Cancer assay
CN118359714B (zh) * 2024-06-14 2024-10-22 浙江莱阅病理诊断科技有限公司 一种抗mcm2鼠单克隆抗体及其制备方法和免疫组化试剂的应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000511291A (ja) * 1997-10-21 2000-08-29 キャンサー リサーチ キャンペーン テクノロジー リミティド 細胞の増殖異常の測定
WO2005026211A2 (en) * 2003-09-05 2005-03-24 Eli Lilly And Company Anti-ghrelin antibodies
GB0708002D0 (en) * 2007-04-25 2007-06-06 Univ Sheffield Antibodies
GB201509907D0 (en) * 2015-06-08 2015-07-22 Urosens Ltd Antibodies

Also Published As

Publication number Publication date
CN107810200A (zh) 2018-03-16
CN107810200B (zh) 2021-04-06
JP2020156486A (ja) 2020-10-01
EP3221352A1 (en) 2017-09-27
US20210277142A1 (en) 2021-09-09
EP3221352B1 (en) 2018-05-09
WO2016198834A1 (en) 2016-12-15
JP2018520127A (ja) 2018-07-26
GB201509907D0 (en) 2015-07-22
JP2022165963A (ja) 2022-11-01
US20180186892A1 (en) 2018-07-05
ES2678049T3 (es) 2018-08-08

Similar Documents

Publication Publication Date Title
US9823251B2 (en) Anti-Uroplakin II antibodies systems and methods
KR101984554B1 (ko) 췌장암의 검출 방법
US9417243B2 (en) Systems and methods for anti-PAX8 antibodies
TR201808196T4 (tr) Mcm5 bağlayan monoklonal antikorlar.
WO2015004603A1 (en) Anti-pla2r antibody and uses thereof
JP7359390B2 (ja) チクングニアウイルスに対する抗体またはその抗原結合断片、およびその用途
AU2023352867A1 (en) Anti-human homeobox protein nkx-2.1 antibodies for use in immunohistochemistry (ihc) protocols and for diagnosing cancer
JP2012500818A (ja) ヒトｅｐｏ受容体に対する抗体
US10316103B1 (en) Systems and methods for anti-Uroplakin III antibodies
US20230331865A1 (en) Antibodies for use in immunohistochemistry (ihc) protocols to diagnose cancer
US20260049142A1 (en) Anti-human icos antibodies for use in immunohistochemistry (ihc) protocols and for diagnosing cancer
US20240426827A1 (en) Anti-human cd10 antibodies for use in immunohistochemistry (ihc) protocols to diagnose cancer
CN108727493B (zh) 抗Stathmin单克隆抗体及其用途